Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia

Koutaro Takamatsu, Shunya Nakane, Shigeaki Suzuki, Takayuki Kosaka, Satoshi Fukushima, Toshihiro Kimura, Azusa Miyashita, Akihiro Mukaino, Shiori Yamakawa, Keisuke Watanabe, Masatoshi Jinnin, Yoshihiro Komohara, Hironobu Ihn, Yukio Ando

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Immune checkpoint inhibitors sometimes cause neuromuscular adverse events. Although a few cases of myasthenia gravis with hyperCKemia triggered by immune checkpoint inhibitors have been described, conclusive evidence remains limited. We conducted a systematic review of published cases of myasthenia gravis with hyperCKemia related to immune checkpoint inhibitors. Moreover, we tested anti-striational antibodies in the case of myasthenia gravis with myositis after nivolumab administration. We located 17 published case reports. Anti-striational antibodies were tested in six cases and five cases were positive. Our systematic analyses revealed poor prognosis in myasthenia gravis combined hyperCKemia with immune checkpoint inhibitors.

Original languageEnglish
JournalAnnals of Clinical and Translational Neurology
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Myasthenia Gravis
Anti-Idiotypic Antibodies
Myositis

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia. / Takamatsu, Koutaro; Nakane, Shunya; Suzuki, Shigeaki; Kosaka, Takayuki; Fukushima, Satoshi; Kimura, Toshihiro; Miyashita, Azusa; Mukaino, Akihiro; Yamakawa, Shiori; Watanabe, Keisuke; Jinnin, Masatoshi; Komohara, Yoshihiro; Ihn, Hironobu; Ando, Yukio.

In: Annals of Clinical and Translational Neurology, 01.01.2018.

Research output: Contribution to journalArticle

Takamatsu, K, Nakane, S, Suzuki, S, Kosaka, T, Fukushima, S, Kimura, T, Miyashita, A, Mukaino, A, Yamakawa, S, Watanabe, K, Jinnin, M, Komohara, Y, Ihn, H & Ando, Y 2018, 'Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia', Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.654
Takamatsu, Koutaro ; Nakane, Shunya ; Suzuki, Shigeaki ; Kosaka, Takayuki ; Fukushima, Satoshi ; Kimura, Toshihiro ; Miyashita, Azusa ; Mukaino, Akihiro ; Yamakawa, Shiori ; Watanabe, Keisuke ; Jinnin, Masatoshi ; Komohara, Yoshihiro ; Ihn, Hironobu ; Ando, Yukio. / Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia. In: Annals of Clinical and Translational Neurology. 2018.
@article{b1017a6f061b4457b7c976aa778c980b,
title = "Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia",
abstract = "Immune checkpoint inhibitors sometimes cause neuromuscular adverse events. Although a few cases of myasthenia gravis with hyperCKemia triggered by immune checkpoint inhibitors have been described, conclusive evidence remains limited. We conducted a systematic review of published cases of myasthenia gravis with hyperCKemia related to immune checkpoint inhibitors. Moreover, we tested anti-striational antibodies in the case of myasthenia gravis with myositis after nivolumab administration. We located 17 published case reports. Anti-striational antibodies were tested in six cases and five cases were positive. Our systematic analyses revealed poor prognosis in myasthenia gravis combined hyperCKemia with immune checkpoint inhibitors.",
author = "Koutaro Takamatsu and Shunya Nakane and Shigeaki Suzuki and Takayuki Kosaka and Satoshi Fukushima and Toshihiro Kimura and Azusa Miyashita and Akihiro Mukaino and Shiori Yamakawa and Keisuke Watanabe and Masatoshi Jinnin and Yoshihiro Komohara and Hironobu Ihn and Yukio Ando",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/acn3.654",
language = "English",
journal = "Annals of Clinical and Translational Neurology",
issn = "2328-9503",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia

AU - Takamatsu, Koutaro

AU - Nakane, Shunya

AU - Suzuki, Shigeaki

AU - Kosaka, Takayuki

AU - Fukushima, Satoshi

AU - Kimura, Toshihiro

AU - Miyashita, Azusa

AU - Mukaino, Akihiro

AU - Yamakawa, Shiori

AU - Watanabe, Keisuke

AU - Jinnin, Masatoshi

AU - Komohara, Yoshihiro

AU - Ihn, Hironobu

AU - Ando, Yukio

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Immune checkpoint inhibitors sometimes cause neuromuscular adverse events. Although a few cases of myasthenia gravis with hyperCKemia triggered by immune checkpoint inhibitors have been described, conclusive evidence remains limited. We conducted a systematic review of published cases of myasthenia gravis with hyperCKemia related to immune checkpoint inhibitors. Moreover, we tested anti-striational antibodies in the case of myasthenia gravis with myositis after nivolumab administration. We located 17 published case reports. Anti-striational antibodies were tested in six cases and five cases were positive. Our systematic analyses revealed poor prognosis in myasthenia gravis combined hyperCKemia with immune checkpoint inhibitors.

AB - Immune checkpoint inhibitors sometimes cause neuromuscular adverse events. Although a few cases of myasthenia gravis with hyperCKemia triggered by immune checkpoint inhibitors have been described, conclusive evidence remains limited. We conducted a systematic review of published cases of myasthenia gravis with hyperCKemia related to immune checkpoint inhibitors. Moreover, we tested anti-striational antibodies in the case of myasthenia gravis with myositis after nivolumab administration. We located 17 published case reports. Anti-striational antibodies were tested in six cases and five cases were positive. Our systematic analyses revealed poor prognosis in myasthenia gravis combined hyperCKemia with immune checkpoint inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=85053732642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053732642&partnerID=8YFLogxK

U2 - 10.1002/acn3.654

DO - 10.1002/acn3.654

M3 - Article

AN - SCOPUS:85053732642

JO - Annals of Clinical and Translational Neurology

JF - Annals of Clinical and Translational Neurology

SN - 2328-9503

ER -